Clinical Trials
67 trialsA Phase 1 Study of the Safety and Tolerability of CTX-10726
Compass Therapeutics
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
National Institutes of Health Clinical Center (CC)
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
BeOne Medicines
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
SEED Therapeutics, Inc.
AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease
University of Southern California
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Alnylam Pharmaceuticals
STELLAR-002
Exelixis
To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors
Shenzhen Xinhe Biomedical
IMFINZI-subQ
AstraZeneca
An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma
Guangzhou FineImmune Biotechnology Co., LTD.
A Study of DEG6498 in Participants With Solid Tumors
Degron Therapeutics Co.
A Study of ZW251 in Participants With Advanced Solid Tumors
Zymeworks BC Inc.
Indocyanine Green (ICG) Guided Tumor Resection
St. Jude Children's Research Hospital
Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab
University of California, San Diego
Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
University of Hawaii
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Seagen Inc.
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
M.D. Anderson Cancer Center
BANTAM-01
Bayer
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Nammi Therapeutics Inc
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
National Institutes of Health Clinical Center (CC)
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
Aptamer Sciences, Inc.
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Shanghai Henlius Biotech
IDOV-Immune for Advanced Solid Tumors
ViroMissile, Inc.
SBRT With Atezo/Bev for HCC
Abramson Cancer Center at Penn Medicine
A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
IMPACT
Seattle Children's Hospital
MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
Suzhou Mednovo Yi Medical Technology Co., Ltd.
A Study of MGC026 in Participants With Advanced Solid Tumors
MacroGenics
TGI5
Hefei TG ImmunoPharma Co., Ltd.
Sapu003 in Advanced mTOR-sensitive Solid Tumors
SAPU NANO (US) LLC
SIM0610-101
Jiangsu Simcere Pharmaceutical Co., Ltd.
A Phase I Study of CREPT-618 in Locally Advanced HCC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
Zhejiang University
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
M.D. Anderson Cancer Center
KARCHER-1
University Hospital, Lille
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Myeloid Therapeutics
JMT106 Injection in the Treatment of Advanced Solid Tumors
Shanghai JMT-Bio Inc.
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
Shanghai Ruiliyuan Biotechnology Co., Ltd.
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
West China Hospital
SURF431
Tyra Biosciences, Inc
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Baylor College of Medicine
A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
Chiome Bioscience Inc.
SIRT With Tremelimumab and Durvalumab for Resectable HCC
Dana-Farber Cancer Institute
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
GONGCHU Biotechnology Co., Ltd
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma
West China Hospital
PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma
Chinese PLA General Hospital
A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors
HC Biopharma Inc.
Autologous HBV-TCR T Cell Therapy (LioCyx-M) for the Treatment of Hepatocellular Carcinoma
Lion TCR Pte. Ltd.
Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma
National University Hospital, Singapore